Such a discrepancy between experimental and clinical results may be explained by the role of resistin in atherosclerosis onset and plaque development [49], one of the major causes of ischemic stroke in humans which is usually not represented in experimental models of ischemic stroke. This evidence concerns the gene RETN and ischemic stroke.